Pharmaceutical News, Pharma, Biotech News & Medical Diagnostics at WSJ.com

WSJ
- WSJ
- Facebook
- Twitter
MarketWatch
- MarketWatch
Barron's
- Barron's
SmartMoney
- SmartMoney
AllThingsDigital
- AllThingsDigital
FINS
- FINS
Factiva
- Factiva
More
- BigCharts
- Virtual Stock Exchange
- Financial News
- WSJ Asia
- WSJ Europe
  - WSJ Deutschland
- WSJ Americas
  - en Español
  - em Português
- WSJ Classifieds
- WSJ Radio
- WSJ Wine

World » More

World » More

Loading…
U.S. » More

U.S. » More

Loading…
New York » More

New York » More

Loading…
Business » More

Business » More

Loading…
Markets » More

Markets » More

Loading…
Tech » More

Tech » More

Loading…
Personal Finance » More

Personal Finance » More

Loading…
Life & Culture » More

Life & Culture » More

Loading…
Opinion » More

Opinion » More

Loading…
Careers » More

Careers » More

Loading…
Real Estate » More

Real Estate » More

Loading…
Small Business » More

Small Business » More

Loading…

Subscriber Content Read Preview

Lawmakers To Vote on FDA Clout
The Senate could vote as soon as next week on whether to give the Food and Drug Administration broader regulatory authority, including new powers to prevent prescription-drug shortages.
Subscriber Content Read Preview

Drug Plan Draws Fire in India
India's government is facing stiff resistance from foreign and local pharmaceutical companies over its plan to severely limit prices for drugs.
Subscriber Content Read Preview

FDA Approves Generic Versions of Plavix
The U.S. Food and Drug Administration on Thursday approved generic versions of blood-thinning drug Plavix.
Subscriber Content Read Preview

Human Genome Adopts Poison Pill
Human Genome Sciences adopted a shareholder rights plan with a 15% trigger in the wake of Glaxo's $2.6 billion hostile takeover bid for the biotech firm.
Subscriber Content Read Preview

Drug Trial Boosts Hope for Tailored Treatment
Pfizer's drug Xalkori for adult lung cancer is showing promise against childhood cancers, illustrating how personalized medicine is emerging as a weapon against pediatric malignancies.
- Study: J&J's Zytiga Can Eliminate Some Prostate Tumors
Subscriber Content Read Preview

Federal Probe of Medtronic Ends
Subscriber Content Read Preview

Zytiga Can Nix Some Prostate Tumors
Subscriber Content Read Preview

Indian Group to Buy U.S. Health Firm
Subscriber Content Read Preview

Cardinal, U.S. in Settlement
Subscriber Content Read Preview

Takeda Open to More Deals
More

Latest Pharmaceuticals & Biotech Headlines

FromDow Jones Newswires

More Industries

Subscriber Content

View an interactive map that shows you how stocks in the Pharmaceuticals & Biotech sector are doing today, at a glance.

Get in-depth research on Pharmaceuticals & Biotech companies, including complete news and financials, earnings estimates and more.

Job Opportunities POST A JOB

MORE JOBS AND CAREER NEWS

FINS for Employers & Recruiters »POST A JOB

Ask a question about anything you choose, and let readers from the Journal Community answer it.

Notify me when I receive answers

*Required

Journal Community

close window

Hello

Your question to the Journal Community Your comments on articles will show your real name and not a username.Why?

Create a Journal Community profile to avoid this message in the future. (As a member you agree to use your real name when participating in the Journal Community)